The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline. As a result, momentum is typically favored in short-term and active trading stra.... |
Good MorningEquity markets started the week on weakened footing following the start of Trump's tariffs. However, the news isn't all bad. Investors bought the early morning weakness, leaving the S&P 500 well off the session's lows by the day's end. The takeaway is that Trump's tariffs will likely cause market volatility, but the upward trend is intact, and new all-time-high index prices are possible.
Earnings will help drive the action this week. After the Monday close, an after-hours report from Palantir underscored the impact of AI on business, leading its stock to a 15% gain. Other critical reports include Advanced Micro Devices, Amazon, and Google, all expected to report solidly.
Critical economic data is also expected this week. Monthly labor data are due, including the ADP, Challenger, JOLTs, and non-farm payroll reports. The consensus is that the data align with trends, including steady job creation, low unemployment, and rising wages. Featured: Boring, cheap, and paying 6% (Ad) 
| Healthcare | |
The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline. As a result, momentum is typically favored in short-term and active trading stra... Read the Full Story |
| From Our Partners | | One fund holds Nvidia, CrowdStrike, Palantir and other major AI names, and pays a 34% annualized distribution rate.
Instead of guessing which AI stock wins, this fund delivers income every single Thursday, up to $1,051 a month.
Chief Income Strategist Tim Plaehn breaks down what's inside the fund and how the weekly payouts work. | | Watch the free video to see how the weekly payouts work |
| Markets | |
Starting small is usually good advice when beginning a new endeavor. If you’re trying to get back in shape, a quick run or light workout is a better starting point than a marathon. However, that logic is counterintuitive when it comes to stocks. Bigger stocks tend to be safer and less volati... Read the Full Story |
| Consumer Discretionary | |
Insider buying was solid in January, including dividend-paying names like Lakeland Industries (NASDAQ: LAKE), York Water (NASDAQ: YORW), and RLI Corp (NYSE: RLI). These stocks are not only the most bought dividend stocks insiders bought but the most bought for the month, news that raises the quest... Read the Full Story |
| From Our Partners | | Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.
A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful. | | See the 7 stocks on the watchlist while it's still free |
| Consumer Staples | |
The Wall Street Journal pointed out a peculiar new trend on social media, where influencers are not showcasing their lavish purchases but rather going the opposite route, embracing a “No Buy” trend. Consumers are tired of inflation and lofty credit card interest rates and have deemed 2... Read the Full Story |
| Healthcare | |
Teva Pharmaceuticals Industries Ltd (NYSE: TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line of branded drugs driving growth.
Its specialty medicines address specific conditions, incl... Read the Full Story |
| From Our Partners | | Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade.
This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan. | | Claim your free options guide and start building real trading knowledge |
| Finance | |
Three S&P 500 Index constituents, as well as one of the world’s biggest names in oil and gas, are raising dividends as 2025 gets started. The firm not in the S&P 500 also announced billions in new buyback authorization. All dividend yield and return metrics use prices as of the Jan. ... Read the Full Story |
| Consumer Staples | |
Global consumer products manufacturer Proctor & Gamble Co. (NYSE: PG) posted upbeat earnings in its fourth quarter of 2024.
The consumer staples sector leader sells well-known grooming, baby, personal care, and hygiene products under brands like Pampers, Luvs, Bounce, Downy, Gain, Tide, Bo... Read the Full Story |
| Markets | |
One of the top-performing sectors YTD has been financials, with the popular financial ETF, Financial Select Sector SPDR (NYSEARCA: XLF), already up 6.5% as of Friday’s close. Conversely, one of the sectors that outperformed for the first three quarters of last year, utilities, represented by... Read the Full Story |
| Consumer Discretionary | |
The 2024 holiday shopping season was a robust one. However, January has been nicknamed 'Returnuary' after the age-old tradition of returning products to retailers every year. The National Retail Federation (NRF) estimates a 17% return rate for all U.S. merchandise this year, which is equal to $890... Read the Full Story |
| Industrials | |
With a market capitalization of $265 million, Palladyne AI Corp. (NASDAQ: PDYN) remains a small software firm. However, its massive growth in the last year has provided it momentum far outpacing some of the trendiest larger companies—NVIDIA Corp.'s (NASDAQ: NVDA) 103% return in the year le... Read the Full Story |
| Tuesday's Early Bird Stock Of The Day CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. | Should I Buy CVS Health Stock? CVS Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of CVS Health was last updated on Monday, October 12, 2026 at 6:55 PM.
CVS Health Bull Case -
CVS Health Co. recently reported strong third-quarter earnings, beating analyst expectations with an actual earnings per share of $2.58 compared to the consensus estimate of $1.87, demonstrating the company's ability to outperform market forecasts and drive shareholder value through operational efficiency.
-
The stock is currently trading at $87.93, which is significantly below the consensus price target of $107.24 set by Wall Street analysts, suggesting a potential upside of approximately 22% for investors who believe the market is currently undervaluing the company's turnaround efforts.
-
CVS Health Co. has raised its full-year 2026 earnings per share guidance to a range of $7.90 to $8.10, which is well above the previous consensus estimate of $7.44, indicating management's confidence in sustained revenue growth and cost management throughout the remainder of the fiscal year.
-
The company offers a dividend yield of 3.03%, providing a steady income stream for investors, which is particularly attractive given the stock's recent volatility and its position near the lower end of its 52-week trading range between $69.51 and $110.68.
-
Recent institutional activity shows positive momentum, with firms like Farther Finance Advisors LLC increasing their holdings by 30.6% in the third quarter, signaling that professional investors are accumulating shares and potentially identifying a long-term value opportunity in the healthcare sector.
CVS Health Bear Case -
CVS Health Co. faces significant regulatory and reputational risk following the initiation of an investigation by Kahn Swick & Foti, LLC into the company's officers and directors, which could lead to legal costs, management distraction, and potential financial liabilities that are not yet reflected in the current stock price.
-
The company's Aetna unit received weaker-than-expected Medicare Advantage star ratings for 2027, with TD Cowen estimating this could result in a $0.41 hit to earnings per share, highlighting ongoing challenges in maintaining high-quality clinical performance and member satisfaction in a competitive insurance market.
-
Despite recent earnings beats, the stock has experienced a sharp retreat from its summer highs, with a gap down of 10.7% observed in August 2026, suggesting that investors may be pricing in structural headwinds such as increasing medical costs and reimbursement pressures that could limit future profitability.
-
CVS Health Co. carries a debt-to-equity ratio of 0.74 and a current ratio of 0.87, indicating that the company has more short-term liabilities than current assets, which could constrain its financial flexibility and ability to invest in growth initiatives during periods of economic uncertainty.
-
Recent insider selling activity, including large block sales by Director Larry Robbins in May 2026, may signal a lack of confidence among company insiders regarding the stock's near-term valuation, potentially dampening retail investor sentiment and limiting upward price momentum.
| | View Today's Stock Pick |
|
| |
|
|
